An artificial amino acid, 4-iodo-L-meta-tyrosine: Biodistribution and excretion via kidney

Journal of Nuclear Medicine

Volumn 44, Issue 4, 2003, Pages 625-631

  Shikano, Naoto ^a   Kawai, Keiichi ^b   Flores II, Leo Garcia ^c   Nishii, Ryuichi ^c   Kubota, Nobuo ^a   Ishikawa, Nobuyoshi ^a   Kubodera, Akiko ^d  

^a IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

4 iodo L meta tyrosine; Amino acid transport; Artificial amino acid; LLC PK1; SPECT

Indexed keywords

2,4 DINITROPHENOL; 3 IODO ALPHA METHYLTYROSINE I 125; 4 IODO 3 TYROSINE; 4 IODO 3 TYROSINE I 125; AMINO ACID DERIVATIVE; AMINO ACID TRANSPORTER; DRUG METABOLITE; MARKER; PHOSPHATE; PROBENECID; PROTEIN; RADIOPHARMACEUTICAL AGENT; SODIUM ION; TRACER; TYROSINE; TYROSINE C 14; UNCLASSIFIED DRUG; 3 IODO ALPHA METHYLTYROSINE; 3-IODO-ALPHA-METHYLTYROSINE; AMINO ACID; CARBON; METIROSINE; RADIOACTIVE IODINE;

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; BRAIN; CELL CULTURE; CELL LINE; CLINICAL OBSERVATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CLEARANCE; DRUG EXCRETION; DRUG MECHANISM; DRUG SCREENING; ENERGY; EPITHELIUM CELL; FECES; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY; KIDNEY CELL; KIDNEY CORTEX; MALE; METABOLISM; MONOLAYER CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS; PLASMA CLEARANCE; PRIORITY JOURNAL; TEMPERATURE; TIME; URINARY EXCRETION; URINE; ANIMAL; ANTIBODY SPECIFICITY; CYTOLOGY; DRUG EFFECT; EVALUATION; FEASIBILITY STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; SENSITIVITY AND SPECIFICITY; SWINE; SYNTHESIS; TISSUE DISTRIBUTION; VALIDATION STUDY;

AMINO ACIDS; ANIMALS; AUTORADIOGRAPHY; CARBON RADIOISOTOPES; CELL LINE; EPITHELIAL CELLS; FEASIBILITY STUDIES; FEMALE; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; KIDNEY; METHYLTYROSINES; MICE; MICE, INBRED STRAINS; ORGAN SPECIFICITY; PROBENECID; SENSITIVITY AND SPECIFICITY; SWINE; TISSUE DISTRIBUTION; TYROSINE;

EID: 0037639947     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kawai K, Flores LG H, Nakagawa M, et al. Brain uptake of iodinated L-meta-tyrosine, a metabolically stable amino acid derivative. Nucl Med Commun. 1999;20:153-157.
2. 123I]iodo-m- tyrosine. a potential SPECT brain imaging agent J Labelled Compas Radiopharm. 1989; 28:1065-1072.
3. Flores LG II, Kawai K, Nakagawa M, et al. A new radiopharmaceutical for the cerebral dopaminergic presynaptic function: 6-radioiodmated L-meta-tyrosine. J Cereb Blood Flow Metab. 2000;20:207-212.
4. 1. In Vitro Cell Dev Biol Anim. 1976;12:670-677.
5. 1. Nippon Jinzo Gakkai Shi. 1996;38:435-440.
6. 1): a model system for aminoglycoside nephrotoxicity. J Pharmacol Exp Ther. 1984;230: 742-748.
7. 1. Biochem J. 1985;227:199-203.
8. 1). Am J Physiol. 1988;254: C251-C257.
9. 1). Biochem Biophys Acta. 1984; 769:514-518.
10. 1 renal epithelial cells. Biochim Biophys Acta. 1989;885:233-239.
11. Kawai K, Fujibayashi Y, Saji H, et al. A strategy for the study of amino acid transport using iodine 123-labeled amino acid radiopharmaceutical 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med. 1991;32:819-824.
12. 123I-3-iodo-alpha-methyl L-tyrosine. Ann Nucl Med. 1992; 6:169-175.
13. Brazeau P. Inhibitors of tubular transport of organic compounds. In: Goodman L, Gilman A, eds. The Pharmacologic Basis of Therapeutics. New York, NY: MacMillan Publishing, Inc.; 1975:862-863.
14. 1): the basolateral systems. J Biol Chem. 1982;257:6802-6808.
15. Forster RP, Copenhaver JH. Intracellular accumulation as an active process in a mammalian renal transport system in vitro Am J Physiol. 1956;186:167-171.
16. Rosenberg LE, Blair A, Segat S Transport of amino acid by slices of rat-kidney cortex. Biochim Biophys Acta. 1961;54:479-488.
17. Christensen HN. Role of amino acid transport and counter-transport in nutrition and metabolism. Physiol Rev 1990;70:43-77.
18. Volkow ND, Fowler JS Neuropsychiatric disorders investigation of schizophrenia and substance abuse. Semin Nucl Med. 1992;22:254-267.
19. 18F]fluoroethyl)-L-tyrosine for tumor imaging J Nucl Med. 1999;40:205-212.
20. Inoue T, Tomiyoshi K, Higuichi T, et al Biodistribution studies on L-3-[fluorine-18]fluoro-α-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med. 1998;39:663-667.
21. 123I]iodo-α-methyl tyrosine: competition with natural L-amino acids. J Nucl Med. 1991;32:1225-1228.
22. 124IMT and first clinical results. J Nucl Med. 1990;31:281-286.
23. Kloss G, Leven M Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanomas. Eur J Nucl Med. 1979;4:179-186.
24. Inoue T, Koyama K, Oriuchi N, et al. Detection of malignant tumors: whole-body PET with fluorine 18 a-methyl tyrosine versus FDG: preliminary study Radiology. 2001;220:54-62.
25. Verbruggen AM, Nosco DL, Nerom CG, et al. Technetium-99m-L. L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals J Nucl Med. 1992;33:551-557.
26. 123I]-α-methyl-L-tyrosine mediate in kidney cortex? a new type renal radiopharmaceutical for functional imaging. J Labelled Compds Radiopharm 1999; 42:652-654.
27. Segal S, Their SO. Handbook of Physiology: Renal Physiology. Washington, DC: American Physiological Society; 1973.
28. Williams WM, Hang KC In vitro and in vivo renal tubular transport of tryptophan derivatives. Am J Physiol. 1970;219:1468-1475.
29. Williams WM, Hang KC. Structural specificity in the renal tubular transport of tyrosine. J Pharmacol Exp Ther. 1981;219:69-74.
30. Palacin M, Estevez R, Bertan J, Zorzano A Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev. 1998;76:969-1054.
31. Maenz DD, Patience JF. L-Threonine transport in pig jejunal brush border membrane: functional characterization of the unique system B in the intestinal epithelium. J Biol Chem. 1992;267:22079-22086.
32. +- dependent transporter for alanine, glutamine, leucine and phenylalanine in brush-border membrane vesicles from bovine kidney. Biochim Biophys Acta 1987;899:176-184.
33. 0,- AT) of rBAT. Nat Genet. 1999;23:52-57.
34. Jager PL, Vaalburg W, Pruim J, Vries EGE, Langen K-J, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-445.